What changed
Humana commenced cash tender offers to purchase up to $1,500,000,000 aggregate purchase price of eight series of senior notes, subject to proration and acceptance priority levels. The offers include an $800,000,000 cap on the aggregate principal amount of the 5.375% Senior Notes due 2031, which may be subject to proration due to both the acceptance priority procedures and the series cap. The notes range from 1.350% Senior Notes due 2027 to 2.150% Senior Notes due 2032. Humana may eliminate, increase or decrease the tender cap and series cap.
Why it matters
Humana commenced cash tender offers to purchase up to $1,500,000,000 aggregate purchase price of eight series of senior notes, subject to proration and acceptance priority levels. The offers include a